
Evaluating Nigeria’s antimalarial drug policies since 1999
From the abstract: “This study applies a formal economic evaluation framework—integrating both cost-effectiveness analysis (CEA) and cost-benefit analysis (CBA)—to assess and compare anti-malarial drug policies across different presidential regimes.”








